Please try another search
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1179 | 977 | 1227 | 1392 | 1653 | 2591 |
Fund Return | 17.92% | -2.34% | 22.67% | 11.66% | 10.57% | 9.99% |
Place in category | 119 | 548 | 122 | 61 | 142 | 152 |
% in Category | 11 | 56 | 11 | 11 | 28 | 55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SEB Sverige Indexfond Institutional | 42.82B | 10.62 | 2.11 | 10.76 | ||
SEB Sverige Indexfond | 42.82B | 9.80 | 0.88 | 10.20 | ||
SEB Sverige Indexfond utd | 42.82B | 9.80 | 0.88 | 10.20 | ||
SEB Varldenfond | 41.09B | 14.00 | 7.43 | 7.10 | ||
SEB Sverigefond Smabolag C R | 25.72B | 15.77 | 1.32 | 17.84 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Handelsbanken Halsovard Tema A1 SEK | 24.14B | 18.95 | 11.66 | 13.26 | ||
Swedbank Robur Medica | 18.2B | 16.52 | 9.84 | 10.05 | ||
SE0016828800 | 64.29M | 13.81 | -6.20 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.45 | 793.99 | -0.29% | |
UnitedHealth | US91324P1021 | 7.75 | 503.15 | -0.63% | |
Novo Nordisk B | DK0062498333 | 7.18 | 622.6 | +5.67% | |
Merck&Co | US58933Y1055 | 5.42 | 99.31 | -0.06% | |
AstraZeneca | GB0009895292 | 5.13 | 10,478.0 | +0.54% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review